CoChat
Sign Up
Cited by 927Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesNeuroethics, Human Enhancement, Biomedical Innovations

Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Greenhill, Laurence L., Pliszka, Steven, Dulcan, Mina K.·2002·Journal of the American Academy of Child & Adolescent Psychiatry
DOI 10.1097/00004583-200202001-00003
Open this paper in CoChat — free account

Abstract

This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.

Integrity signals

Registry

Crossref · 10.1097/00004583-200202001-00003

Cites

172 of 172 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Psychostimulants are the most widely researched medications for ADHD alone, but findings on their efficacy and safety in co-occurring ADHD and ASD conflict.

    “Psychostimulants are the most widely researched medications used to treat ADHD alone [26], but conflicting findings have been reported regarding the efficacy and safety of stimulants in cases of co-occurring ADHD and ASD.”

    From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [26]

  • Pharmacological treatment for ADHD reduces impairment from core ADHD symptoms and improves functioning in children and adults.

    “Pharmacological treatment for ADHD is effective for reducing impairment associated with core ADHD symptoms (i.e., inattention, hyperactivity, impulsivity) and improving functioning in children and adults [25,26].”

    From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [26]

  • Several studies indicate that combining medication with psychosocial treatment works especially well for managing ADHD symptoms.

    “Multiple studies have demonstrated that combination pharmacological and psychosocial treatments are particularly effective for ADHD symptom management [26,62].”

    From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [26]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Greenhill, L. L., Pliszka, S., & Dulcan, M. K.
ORCID
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2002-02
Volume
41
Issue
2
Pages
26S-49S
ISSN
0890-8567 (ISSN-L)
DOI
10.1097/00004583-200202001-00003
OpenAlex
W2062714266
Semantic Scholar
ceaa70e97dbbecf204e6c78e84f580e56b6eeec0
Cited by
927
References
172
Citations by year
2026: 3 · 2025: 11 · 2024: 15 · 2023: 8 · 2022: 11 · 2021: 17 · 2020: 172 · 2019: 14 · 2018: 15 · 2017: 22 · 2016: 30 · 2015: 22 · 2014: 43 · 2013: 31 · 2012: 34
FWCI
30.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
Keywords
stimulant medication, attention deficit hyperactivity disorder, narcolepsy, methylphenidate, d-amphetamine, amphetamine salts, pemoline, pediatric treatment, adolescents, adults
MeSH terms
Contraindications, Adolescent, Adult, Amphetamines, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Child, Child, Preschool, Humans, Methylphenidate, Narcolepsy, Pemoline, Psychopharmacology, Psychotropic Drugs, United States, Drug Monitoring, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review